This means that it does not have a natural model of action and may potentially cause unwanted side effects during long-term administration
The responsible agent is not known, but we have very recent evidence for presence of amyloid deposition and misfolded proteolipid protein in the brains of progressive MS patients supporting the proteopathic theory (Tsutsui et al., 2024)
Follow-up consultations occur at regular intervals to monitor weight loss progress, adjust doses if needed, and address any side effects or concerns
Patients often report increased energy, reduced joint discomfort, improved sleep, higher self-confidence, and reduced risks associated with heart disease and other obesity-related health conditions
Short chain fatty acids stimulate the production of GLP-1 and other hormones that regulate hunger such as peptide YY (PYY) and cholecystokinin (CCK) which may help reduce excess calorie intake without the side effects and cost of weight loss medications
Direct pharmacological considerations include the medication's mechanism of action and tissue distribution